Analyze Diet
Equine veterinary journal2003; 35(7); 691-695; doi: 10.2746/042516403775696339

Effect of GastroGard and three compounded oral omeprazole preparations on 24 h intragastric pH in gastrically cannulated mature horses.

Abstract: Ulceration of the squamous gastric mucosa is commonly associated with intensive training programmes in horses, but only one compound ('Gastrogard') has been subjected to controlled scrutiny as to therapeutic efficacy. Objective: To compare the gastric acid inhibitory efficacy of one manufactured ('GastroGard') and 3 generic pharmacy-compounded preparations of the proton pump inhibitor omeprazole (OME) in the mature horse. Objective: All OME preparations tested would induce a clinically acceptable effect. Methods: Six healthy mature gastrically cannulated horses of various breeds, 3 mares and 3 geldings, were used. Each product was administered per os once daily (0730 h) at an equivalent dose of 4 mg OME/kg bwt, in a randomised complete repeated measures design for sequence of individual preparation treatment per horse. There was a minimum of 14 days between treatment regimens. A portable unit that recorded pH continuously was attached to a recording electrode fixed within the gastric lumen via the gastric cannula. Three 24 h recordings were made one day before and during Days 2 and 7 after commencement of a 7 day treatment with each of the 4 individual preparations. The horses were fed as usual throughout the study. Results: Only the GastroGard and one other preparation induced a significant increase over baseline in mean percentage of time that the pH was > 4.0 and mean median intragastric pH, during the first 14 and 12 h post treatment respectively, for both Days 2 and 7 post treatment. Both these products had a vehicle pH > 8.0, in contrast to the 2 less effective products, where the vehicle pH was < 6.0. Conclusions: OME at 4 mg/kg per os s.i.d. can effectively maintain intragastric pH at an accepted anti-ulcerogenic level for at least 12 h post administration in mature horses. In contrast to GastroGard, it should not be expected that all compounded preparations of OME are equally effective in achieving this performance. It appears that vehicle pH might play an important part in determining preparation efficacy. Conclusions: Optimal timing for daily dosing of athletic horses with an effective OME preparation, in order to suppress gastric squamous ulceration, might be 4-8 h prior to a training session.
Publication Date: 2003-12-03 PubMed ID: 14649361DOI: 10.2746/042516403775696339Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article studied the effect of a patented drug, GastroGard, and three generic versions of the same drug on gastric acid levels in horses. The results indicated that only Gastrogard and one other preparation were effective in significantly suppressing gastric acid.

Objective and Methodology

  • The purpose of this research was to compare the acid suppressing efficacy of the patented drug Gastrogard, and three generic variations of the medicine.
  • The study was conducted on six mature horses who were monitored using a device that continuously measured their gastric acidity over several days.
  • Each horse was treated with the four different medicines individually with a gap of a minimum 14 days between each regimen.

Results

  • The results revealed that only Gastrogard and one other preparation were able to significantly enhance the mean percentage of time when the gastric acidity (pH) was over 4.0.
  • The study found that these two effective products also had a vehicle pH over 8.0, contrasting sharply with the less effective products, which had a vehicle pH less than 6.0.
  • This implies that the pH level of the vehicle (the substance in which the drug is dissolved for administration) may likely influence the preparation’s effectiveness.

Conclusion

  • The experiment concluded that the drug omeprazole administered at 4 mg per kg can effectively maintain gastric pH at a level that helps prevent ulcers in mature horses for at least 12 hours post-administration.
  • However, this research also indicated that not all variations of the same drug have the same potential for effectiveness, highlighting that the pH level of the substance in which it is dissolved may play a significant role in treatment.
  • Findings suggest that for athletic horses, to prevent gastric ulcers, optimal dosing time would be 4-8 hours before a training session utilizing an effective omeprazole preparation.

Cite This Article

APA
Merritt AM, Sanchez LC, Burrow JA, Church M, Ludzia S. (2003). Effect of GastroGard and three compounded oral omeprazole preparations on 24 h intragastric pH in gastrically cannulated mature horses. Equine Vet J, 35(7), 691-695. https://doi.org/10.2746/042516403775696339

Publication

ISSN: 0425-1644
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 35
Issue: 7
Pages: 691-695

Researcher Affiliations

Merritt, A M
  • Island Whirl Equine Colic Research Laboratory, College of Veterinary Medicine, University of Florida, Box 100136, Gainesville, Florida 32610-0136, USA.
Sanchez, L C
    Burrow, J A
      Church, M
        Ludzia, S

          MeSH Terms

          • Administration, Oral
          • Animals
          • Anti-Ulcer Agents / administration & dosage
          • Anti-Ulcer Agents / therapeutic use
          • Drug Compounding / methods
          • Drug Compounding / veterinary
          • Female
          • Gastric Acid / metabolism
          • Gastric Mucosa / drug effects
          • Gastric Mucosa / pathology
          • Horse Diseases / prevention & control
          • Horses
          • Hydrogen-Ion Concentration
          • Male
          • Ointments
          • Omeprazole / administration & dosage
          • Omeprazole / therapeutic use
          • Physical Conditioning, Animal
          • Proton Pump Inhibitors
          • Random Allocation
          • Stomach Ulcer / prevention & control
          • Stomach Ulcer / veterinary
          • Treatment Outcome

          Citations

          This article has been cited 15 times.
          1. Hodgson E, Thirouin M, Narayanan P, Romano TR, Wise J, Bond S. A novel placement method of a calibration-free pH capsule for continuous wireless measurement of intragastric pH in horses. J Vet Intern Med 2025 Jan-Feb;39(1):e17273.
            doi: 10.1111/jvim.17273pubmed: 39715411google scholar: lookup
          2. Clark B, Steel C, Vokes J, Shan JR, Gedye K, Lovett A, Sykes BW. Evaluation of the effects of medium-term (57-day) omeprazole administration and of omeprazole discontinuation on serum gastrin and serum chromogranin A concentrations in the horse. J Vet Intern Med 2023 Jul-Aug;37(4):1537-1543.
            doi: 10.1111/jvim.16795pubmed: 37390114google scholar: lookup
          3. Vokes J, Lovett A, Sykes B. Equine Gastric Ulcer Syndrome: An Update on Current Knowledge. Animals (Basel) 2023 Apr 5;13(7).
            doi: 10.3390/ani13071261pubmed: 37048517google scholar: lookup
          4. Song Y, Day CM, Afinjuomo F, Tan JE, Page SW, Garg S. Advanced Strategies of Drug Delivery via Oral, Topical, and Parenteral Administration Routes: Where Do Equine Medications Stand?. Pharmaceutics 2023 Jan 4;15(1).
            doi: 10.3390/pharmaceutics15010186pubmed: 36678815google scholar: lookup
          5. Hwang H, Dong HJ, Han J, Cho S, Kim Y, Lee I. Prevalence and treatment of gastric ulcers in Thoroughbred racehorses of Korea. J Vet Sci 2022 Mar;23(2):e19.
            doi: 10.4142/jvs.21247pubmed: 35187877google scholar: lookup
          6. Gough S, Hallowell G, Rendle D. Evaluation of the treatment of equine glandular gastric disease with either long-acting-injectable or oral omeprazole. Vet Med Sci 2022 Mar;8(2):561-567.
            doi: 10.1002/vms3.728pubmed: 35167731google scholar: lookup
          7. Hewetson M, Tallon R. Equine Squamous Gastric Disease: Prevalence, Impact and Management. Vet Med (Auckl) 2021;12:381-399.
            doi: 10.2147/VMRR.S235258pubmed: 35004264google scholar: lookup
          8. Baptista R, Englar R, São Braz B, Leal RO. Survey-Based Analysis of Current Trends for Prescribing Gastrointestinal Protectants among Small-Animal General Practitioners in Portugal. Vet Sci 2021 Apr 23;8(5).
            doi: 10.3390/vetsci8050070pubmed: 33922570google scholar: lookup
          9. Wise JC, Hughes KJ, Edwards S, Jacobson GA, Narkowicz CK, Raidal SL. Pharmacokinetic and pharmacodynamic effects of 2 registered omeprazole preparations and varying dose rates in horses. J Vet Intern Med 2021 Jan;35(1):620-631.
            doi: 10.1111/jvim.15971pubmed: 33340169google scholar: lookup
          10. Wise JC, Raidal SL, Wilkes EJA, Hughes KJ. Intragastric pH of foals admitted to the intensive care unit. J Vet Intern Med 2020 Nov;34(6):2719-2726.
            doi: 10.1111/jvim.15888pubmed: 32990384google scholar: lookup
          11. Mullen KR, Yasuda K, Divers TJ, Weese JS. Equine faecal microbiota transplant: Current knowledge, proposed guidelines and future directions. Equine Vet Educ 2018 Mar;30(3):151-160.
            doi: 10.1111/eve.12559pubmed: 32313396google scholar: lookup
          12. Gough S, Hallowell G, Rendle D. A study investigating the treatment of equine squamous gastric disease with long-acting injectable or oral omeprazole. Vet Med Sci 2020 May;6(2):235-241.
            doi: 10.1002/vms3.220pubmed: 31945806google scholar: lookup
          13. Marks SL, Kook PH, Papich MG, Tolbert MK, Willard MD. ACVIM consensus statement: Support for rational administration of gastrointestinal protectants to dogs and cats. J Vet Intern Med 2018 Nov;32(6):1823-1840.
            doi: 10.1111/jvim.15337pubmed: 30378711google scholar: lookup
          14. Sykes BW, Hewetson M, Hepburn RJ, Luthersson N, Tamzali Y. European College of Equine Internal Medicine Consensus Statement--Equine Gastric Ulcer Syndrome in Adult Horses. J Vet Intern Med 2015 Sep-Oct;29(5):1288-99.
            doi: 10.1111/jvim.13578pubmed: 26340142google scholar: lookup
          15. Husted L, Jensen TK, Olsen SN, Mølbak L. Examination of equine glandular stomach lesions for bacteria, including Helicobacter spp by fluorescence in situ hybridisation. BMC Microbiol 2010 Mar 19;10:84.
            doi: 10.1186/1471-2180-10-84pubmed: 20298612google scholar: lookup